Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Production and Sales of Pharmaceutical Raw Materials			447.58M	442.87M	420.89M	367.06M	311.01M
Production and Sales of Pharmaceutical Raw Materials Growth			1.07%	5.22%	14.67%	18.02%	14.57%
Total			447.58M	442.87M	420.89M	367.06M	311.01M
Total Growth			1.07%	5.22%	14.67%	18.02%	14.57%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Overseas			97.55M	96.22M	68.74M	49.74M	53.99M
Overseas Growth			1.38%	39.98%	38.19%	-7.86%	-
East China			149.99M	202.29M	182.89M	152.29M	112.23M
East China Growth			-25.86%	10.60%	20.10%	35.69%	-
North China			123.90M	71.44M	53.98M	54.07M	44.55M
North China Growth			73.45%	32.35%	-0.17%	21.37%	-
Central China			17.07M	14.00M	33.03M	44.92M	47.18M
Central China Growth			21.89%	-57.61%	-26.47%	-4.80%	-
Southwest			30.15M	24.79M	27.58M	31.07M	17.00M
Southwest Growth			21.60%	-10.12%	-11.21%	82.75%	-
South China			15.85M	24.58M	44.16M	21.85M	25.64M
South China Growth			-35.52%	-44.33%	102.08%	-14.76%	-
Northeast			7.88M	8.39M	9.13M	10.21M	7.28M
Northeast Growth			-6.10%	-8.07%	-10.58%	40.29%	-
Northwest			5.19M	1.15M	1.37M	1.80M	2.06M
Northwest Growth			352.38%	-16.30%	-23.83%	-12.52%	-
Total			447.58M	442.87M	420.89M	365.95M	309.92M
Total Growth			1.07%	5.22%	15.01%	18.08%	14.17%

Source: S&P Global Market Intelligence.